Handbook of the MedicalConsequences of Alcoholand Drug Abuse

Murphy, L. (1999). Cannabis effects on endocrine and reproductive function. In: Kalant, H.; Corrigall, W.A.; Hall, W.; Smart, R.G. (eds.), Health Effects of Cannabis (pp. 375-400). Toronto: Centre for Addiction and Mental Health.

Negrete, J.C. (1989). Cannabis and schizophrenia. Br J Addict, 84:349-351.

Negrete, J.C.; Gill, K. (1999). Cannabis and schizophrenia: An overview of the evidence to date. In Nahas, G.G. (ed.), Marijuana and Medicine. Totowa, NJ: Humana Press, 671-681.

Newton, C.A.; Klein, T.W.; Friedman, H. (1994). Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by 9-tetrahydrocannabinol injection. Infect Immun, 62:4015-4020.

Nowlan, R.; Cohen, S. (1977). Tolerance to marijuana: Heart rate and subjective “high.” Clin Pharmacol Ther, 22:550-556.

Noyes, R. Jr.; Brunk, S.F.; Avery, D.H.; Canter, A. (1975). The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther, 18:84-89.

Noyes, R. Jr.; Brunk, S.F.; Baram, D.; Canter, A. (1975). Analgesic effect of delta9-tetrahydrocannabinol. J Clin Pharmacol, 15:139-143.

O’Connell, C.M.; Fried, P.A. (1984). An investigation of prenatal cannabis exposure and minor physical anomalies in a low risk population. Neurotoxicol Teratol, 6:345-350.

O’Connell, C.M.; Fried, P.A. (1991). Prenatal exposure to cannabis: A preliminary report of postnatal consequences in school-age children. Neurotoxicol Teratol, 13:631-639.

Peck, R.C.; Biasotti, A.; Boland, P.N.; Mallory, C.; Reeve, V. (1986). The effects of marijuana and alcohol on actual driving performance. Alcohol, Drugs and Driving, 2:135-154.

Perez-Reyes, M.; Hicks, R.E.; Bumberry, J.; Jeffcoat, A.R.; Cook, C.E. (1988). Interaction between marijuana and ethanol: Effects on psychomotor performance.

Alcohol Clin Exp Res, 12:268-276.

Perez-Reyes, M.; Lipton, M.A.; Timmons, M.C.; Walls, M.E.; Brine, D.R.; Davis, K.H. (1973). Pharmacology of administered delta-9-tetrahydrocannabinol. Clin Pharmacol Ther, 14:48-55.

Perez-Reyes, M.; White, W.R.; McDonald, S.A.; Hicks, R.E.; Jeffcoat, A.R.; Cook, C.E. (1991). The pharmocologic effects of daily marijuana smoking in humans.

Pharmacol Biochem Behav, 40:691-694.

Petro, D.C.; Ellenberger, J. (1981). Treatment of human spasticity with delta 9-tetrahydrocannabinol. J Clin Pharmacol, 21:413S-416S. Pickworth, W.B.; Rohrer, M.S.; Fant, R.V. (1997). Effects of abused drugs on psychomotor performance. Exp Clin Psychopharmachol, 5:235-241.

Pihl, R.O.; Sigal, H. (1978). Motivational levels and the marijuana high. J Abnorm Psychol, 87(2):280-285.

Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane, M.; Shepard, K.V.; Wadleigh, R.G. (1991). Recent clinical experience with dronabinol. Pharmacol Biochem Behav, 40:695-700.

Polen, M.R.; Sidney, S.; Tekawa, I.S.; Sadler, M.; Friedman, G.D. (1993). Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med, 158:596-601.